UNITEDHEALTH GROUP INC (UNH.DE) Stock Fundamental Analysis

FRA:UNH • US91324P1021

242.9 EUR
+8.1 (+3.45%)
Last: Feb 13, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

4

UNH gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 29 industry peers in the Health Care Providers & Services industry. While UNH is still in line with the averages on profitability rating, there are concerns on its financial health. UNH is quite expensive at the moment. It does show a decent growth rate. Finally UNH also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • UNH had positive earnings in the past year.
  • In the past year UNH had a positive cash flow from operations.
  • UNH had positive earnings in each of the past 5 years.
  • UNH had a positive operating cash flow in each of the past 5 years.
UNH.DE Yearly Net Income VS EBIT VS OCF VS FCFUNH.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

1.2 Ratios

  • The Return On Assets of UNH (3.89%) is better than 72.41% of its industry peers.
  • UNH's Return On Equity of 12.05% is fine compared to the rest of the industry. UNH outperforms 62.07% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 5.09%, UNH is in line with its industry, outperforming 48.28% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for UNH is above the industry average of 6.49%.
Industry RankSector Rank
ROA 3.89%
ROE 12.05%
ROIC 5.09%
ROA(3y)5.63%
ROA(5y)6.65%
ROE(3y)17.6%
ROE(5y)20.55%
ROIC(3y)8.75%
ROIC(5y)9.53%
UNH.DE Yearly ROA, ROE, ROICUNH.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

1.3 Margins

  • UNH's Profit Margin of 2.69% is in line compared to the rest of the industry. UNH outperforms 58.62% of its industry peers.
  • UNH's Profit Margin has declined in the last couple of years.
  • UNH has a Operating Margin of 4.24%. This is comparable to the rest of the industry: UNH outperforms 51.72% of its industry peers.
  • In the last couple of years the Operating Margin of UNH has declined.
Industry RankSector Rank
OM 4.24%
PM (TTM) 2.69%
GM N/A
OM growth 3Y-21.54%
OM growth 5Y-13.43%
PM growth 3Y-24.29%
PM growth 5Y-14.77%
GM growth 3YN/A
GM growth 5YN/A
UNH.DE Yearly Profit, Operating, Gross MarginsUNH.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so UNH is still creating some value.
  • The number of shares outstanding for UNH has been reduced compared to 1 year ago.
  • The number of shares outstanding for UNH has been reduced compared to 5 years ago.
  • The debt/assets ratio for UNH has been reduced compared to a year ago.
UNH.DE Yearly Shares OutstandingUNH.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M
UNH.DE Yearly Total Debt VS Total AssetsUNH.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100B 200B 300B

2.2 Solvency

  • UNH has a debt to FCF ratio of 4.99. This is a neutral value as UNH would need 4.99 years to pay back of all of its debts.
  • UNH has a Debt to FCF ratio of 4.99. This is in the better half of the industry: UNH outperforms 79.31% of its industry peers.
  • UNH has a Debt/Equity ratio of 0.72. This is a neutral value indicating UNH is somewhat dependend on debt financing.
  • UNH has a better Debt to Equity ratio (0.72) than 68.97% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.72
Debt/FCF 4.99
Altman-Z N/A
ROIC/WACC0.61
WACC8.42%
UNH.DE Yearly LT Debt VS Equity VS FCFUNH.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B 100B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
UNH.DE Yearly Current Assets VS Current LiabilitesUNH.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • UNH shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -41.58%.
  • The Earnings Per Share has been decreasing by -0.67% on average over the past years.
  • Looking at the last year, UNH shows a quite strong growth in Revenue. The Revenue has grown by 11.81% in the last year.
  • UNH shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.72% yearly.
EPS 1Y (TTM)-41.58%
EPS 3Y-9.75%
EPS 5Y-0.67%
EPS Q2Q%-69.02%
Revenue 1Y (TTM)11.81%
Revenue growth 3Y11.35%
Revenue growth 5Y11.72%
Sales Q2Q%12.31%

3.2 Future

  • UNH is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 21.30% yearly.
  • The Revenue is expected to grow by 5.37% on average over the next years.
EPS Next Y10.42%
EPS Next 2Y10.59%
EPS Next 3Y13.39%
EPS Next 5Y21.3%
Revenue Next Year-1.43%
Revenue Next 2Y0.97%
Revenue Next 3Y2.59%
Revenue Next 5Y5.37%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
UNH.DE Yearly Revenue VS EstimatesUNH.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 200B 400B 600B
UNH.DE Yearly EPS VS EstimatesUNH.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10 20 30 40 50

More info and screens

Find the best growth stocksShow best growing peers

3

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 17.68, which indicates a rather expensive current valuation of UNH.
  • Compared to the rest of the industry, the Price/Earnings ratio of UNH indicates a somewhat cheap valuation: UNH is cheaper than 62.07% of the companies listed in the same industry.
  • UNH's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.97.
  • With a Price/Forward Earnings ratio of 16.02, UNH is valued correctly.
  • UNH's Price/Forward Earnings ratio is in line with the industry average.
  • When comparing the Price/Forward Earnings ratio of UNH to the average of the S&P500 Index (27.96), we can say UNH is valued slightly cheaper.
Industry RankSector Rank
PE 17.68
Fwd PE 16.02
UNH.DE Price Earnings VS Forward Price EarningsUNH.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, UNH is valued a bit more expensive than 68.97% of the companies in the same industry.
  • UNH's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 16.62
EV/EBITDA 12.98
UNH.DE Per share dataUNH.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 100 200 300 400

4.3 Compensation for Growth

  • UNH's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • UNH's earnings are expected to grow with 13.39% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.7
PEG (5Y)N/A
EPS Next 2Y10.59%
EPS Next 3Y13.39%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

7

5. Dividend

5.1 Amount

  • UNH has a Yearly Dividend Yield of 3.29%. Purely for dividend investing, there may be better candidates out there.
  • UNH's Dividend Yield is rather good when compared to the industry average which is at 1.61. UNH pays more dividend than 86.21% of the companies in the same industry.
  • UNH's Dividend Yield is rather good when compared to the S&P500 average which is at 1.79.
Industry RankSector Rank
Dividend Yield 3.29%

5.2 History

  • The dividend of UNH is nicely growing with an annual growth rate of 12.43%!
Dividend Growth(5Y)12.43%
Div Incr Years5
Div Non Decr Years5
UNH.DE Yearly Dividends per shareUNH.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2 4 6 8

5.3 Sustainability

  • UNH pays out 65.66% of its income as dividend. This is not a sustainable payout ratio.
  • UNH's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP65.66%
EPS Next 2Y10.59%
EPS Next 3Y13.39%
UNH.DE Yearly Income VS Free CF VS DividendUNH.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B 25B
UNH.DE Dividend Payout.UNH.DE Dividend Payout, showing the Payout Ratio.UNH.DE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

UNITEDHEALTH GROUP INC

FRA:UNH (2/13/2026, 7:00:00 PM)

242.9

+8.1 (+3.45%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)01-27
Earnings (Next)04-15
Inst Owners83.63%
Inst Owner ChangeN/A
Ins Owners0.16%
Ins Owner ChangeN/A
Market Cap220.03B
Revenue(TTM)447.57B
Net Income(TTM)12.06B
Analysts75.15
Price Target324.61 (33.64%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.29%
Yearly Dividend7.37
Dividend Growth(5Y)12.43%
DP65.66%
Div Incr Years5
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.45%
Min EPS beat(2)-0.58%
Max EPS beat(2)3.48%
EPS beat(4)1
Avg EPS beat(4)-2.3%
Min EPS beat(4)-9.92%
Max EPS beat(4)3.48%
EPS beat(8)5
Avg EPS beat(8)0.06%
EPS beat(12)9
Avg EPS beat(12)0.66%
EPS beat(16)13
Avg EPS beat(16)1.45%
Revenue beat(2)0
Avg Revenue beat(2)-1.21%
Min Revenue beat(2)-1.51%
Max Revenue beat(2)-0.91%
Revenue beat(4)0
Avg Revenue beat(4)-1.53%
Min Revenue beat(4)-2.79%
Max Revenue beat(4)-0.91%
Revenue beat(8)1
Avg Revenue beat(8)-1.05%
Revenue beat(12)5
Avg Revenue beat(12)-0.37%
Revenue beat(16)6
Avg Revenue beat(16)-0.33%
PT rev (1m)-7.54%
PT rev (3m)-0.52%
EPS NQ rev (1m)6.45%
EPS NQ rev (3m)2.75%
EPS NY rev (1m)0.43%
EPS NY rev (3m)1.39%
Revenue NQ rev (1m)-3.11%
Revenue NQ rev (3m)-4.57%
Revenue NY rev (1m)-2.85%
Revenue NY rev (3m)-5.07%
Valuation
Industry RankSector Rank
PE 17.68
Fwd PE 16.02
P/S 0.58
P/FCF 16.62
P/OCF 13.51
P/B 2.61
P/tB 2.61
EV/EBITDA 12.98
EPS(TTM)13.74
EY5.66%
EPS(NY)15.17
Fwd EY6.24%
FCF(TTM)14.62
FCFY6.02%
OCF(TTM)17.98
OCFY7.4%
SpS416.11
BVpS93.06
TBVpS93.06
PEG (NY)1.7
PEG (5Y)N/A
Graham Number169.61
Profitability
Industry RankSector Rank
ROA 3.89%
ROE 12.05%
ROCE 6.25%
ROIC 5.09%
ROICexc 5.62%
ROICexgc 21.72%
OM 4.24%
PM (TTM) 2.69%
GM N/A
FCFM 3.51%
ROA(3y)5.63%
ROA(5y)6.65%
ROE(3y)17.6%
ROE(5y)20.55%
ROIC(3y)8.75%
ROIC(5y)9.53%
ROICexc(3y)9.73%
ROICexc(5y)10.65%
ROICexgc(3y)29.49%
ROICexgc(5y)31.32%
ROCE(3y)10.77%
ROCE(5y)11.72%
ROICexgc growth 3Y-15.05%
ROICexgc growth 5Y-8.06%
ROICexc growth 3Y-22.49%
ROICexc growth 5Y-14%
OM growth 3Y-21.54%
OM growth 5Y-13.43%
PM growth 3Y-24.29%
PM growth 5Y-14.77%
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover1.45
Health
Industry RankSector Rank
Debt/Equity 0.72
Debt/FCF 4.99
Debt/EBITDA 3.1
Cap/Depr 83.05%
Cap/Sales 0.81%
Interest Coverage 250
Cash Conversion 82.92%
Profit Quality 130.39%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score7
WACC8.42%
ROIC/WACC0.61
Cap/Depr(3y)84.55%
Cap/Depr(5y)83.03%
Cap/Sales(3y)0.86%
Cap/Sales(5y)0.86%
Profit Quality(3y)129.12%
Profit Quality(5y)123.75%
High Growth Momentum
Growth
EPS 1Y (TTM)-41.58%
EPS 3Y-9.75%
EPS 5Y-0.67%
EPS Q2Q%-69.02%
EPS Next Y10.42%
EPS Next 2Y10.59%
EPS Next 3Y13.39%
EPS Next 5Y21.3%
Revenue 1Y (TTM)11.81%
Revenue growth 3Y11.35%
Revenue growth 5Y11.72%
Sales Q2Q%12.31%
Revenue Next Year-1.43%
Revenue Next 2Y0.97%
Revenue Next 3Y2.59%
Revenue Next 5Y5.37%
EBIT growth 1Y-41.26%
EBIT growth 3Y-12.63%
EBIT growth 5Y-3.28%
EBIT Next Year30.68%
EBIT Next 3Y19.54%
EBIT Next 5Y19.54%
FCF growth 1Y-23.26%
FCF growth 3Y-12.42%
FCF growth 5Y-4.82%
OCF growth 1Y-19.36%
OCF growth 3Y-9.63%
OCF growth 5Y-2.7%

UNITEDHEALTH GROUP INC / UNH.DE FAQ

Can you provide the ChartMill fundamental rating for UNITEDHEALTH GROUP INC?

ChartMill assigns a fundamental rating of 4 / 10 to UNH.DE.


Can you provide the valuation status for UNITEDHEALTH GROUP INC?

ChartMill assigns a valuation rating of 3 / 10 to UNITEDHEALTH GROUP INC (UNH.DE). This can be considered as Overvalued.


Can you provide the profitability details for UNITEDHEALTH GROUP INC?

UNITEDHEALTH GROUP INC (UNH.DE) has a profitability rating of 4 / 10.


What are the PE and PB ratios of UNITEDHEALTH GROUP INC (UNH.DE) stock?

The Price/Earnings (PE) ratio for UNITEDHEALTH GROUP INC (UNH.DE) is 17.68 and the Price/Book (PB) ratio is 2.61.


Is the dividend of UNITEDHEALTH GROUP INC sustainable?

The dividend rating of UNITEDHEALTH GROUP INC (UNH.DE) is 7 / 10 and the dividend payout ratio is 65.66%.